Drug recall · June 25, 2025
Gentamicin Injection recall
Why: Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
- Lots / codes
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
- Quantity
- 48,000 vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA
- Initiated
- May 29, 2025 · Voluntary: Firm initiated
- Classified
- June 18, 2025
- Reported
- June 25, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gentamicin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.